Genetic influences on blood lipids and cardiovascular disease risk: tools for primary prevention

被引:50
|
作者
Ordovas, Jose M. [1 ]
机构
[1] Tufts Univ, Nutr & Genom Lab, USDA, Human Nutr Ctr Aging, 711 Washington St, Boston, MA 02111 USA
来源
AMERICAN JOURNAL OF CLINICAL NUTRITION | 2009年 / 89卷 / 05期
关键词
APOLIPOPROTEIN-E POLYMORPHISM; POSTPRANDIAL LIPOPROTEIN METABOLISM; PROMOTER -219G/T POLYMORPHISM; HEALTH OUTCOMES IMPLICATIONS; ACTIVATED-RECEPTOR-GAMMA; FAT DIETARY PATTERN; SERUM-LIPIDS; E PHENOTYPE; E GENOTYPE; PLASMA-LIPIDS;
D O I
10.3945/ajcn.2009.27113E
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Genetic polymorphism in human populations is part of the evolutionary process that results from the interaction between the environment and the human genome. Recent changes in diet have upset this equilibrium, potentially influencing the risk of most common morbidities such as cardiovascular diseases, obesity, diabetes, and cancer. Reduction of these conditions is a major public health concern, and such a reduction could be achieved by improving our ability to detect disease predisposition early in life and by providing more personalized behavioral recommendations for successful primary prevention. In terms of cardiovascular diseases, polymorphisms at multiple genes have been associated with differential effects in terms of lipid metabolism; however, the connection with cardiovascular disease has been more elusive, and considerable heterogeneity exists among studies regarding the predictive value of genetic markers. This may be because of experimental limitations, the intrinsic complexity of the phenotypes, and the aforementioned interactions with environmental factors. The integration of genetic and environmental complexity into current and future research will drive the field toward the implementation of clinical tools aimed at providing dietary advice optimized for the individual's genome. This may imply that dietary changes are implemented early in life to gain maximum benefit. However, it is important to highlight that most reported studies have focused on adult populations and to extrapolate these findings to children and adolescents may not be justified until proper studies have been carried out in these populations and until the ethical and legal issues associated with this new field are adequately addressed. Am J Clin Nutr 2009; 89(suppl): 1509S-17S.
引用
收藏
页码:S1509 / S1517
页数:9
相关论文
共 50 条
  • [31] Primary Prevention of Cardiovascular Disease
    Eapen, Danny J.
    Schultz, William M.
    Heinl, Robert E.
    Ghasemzadeh, Nima
    Varghese, Tina
    Kurian, Diana E.
    Mathai, Christina E.
    Sandesara, Pratik
    Kindya, Bryan R.
    Allard-Ratick, Marc P.
    Bhatia, Neal K.
    Isiadinso, Ijeoma
    Sperling, Laurence
    CARDIOVASCULAR INNOVATIONS AND APPLICATIONS, 2016, 1 (04) : 379 - 389
  • [32] Primary Prevention of Cardiovascular Disease
    Jain, Atul
    Davis, Andrew M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (18): : 1817 - 1818
  • [33] Primary prevention of cardiovascular disease
    Reckless, John P. D.
    BRITISH MEDICAL JOURNAL, 2011, 342
  • [34] Cardiovascular Genetic Risk Testing for Targeting Statin Therapy in the Primary Prevention of Atherosclerotic Cardiovascular Disease A Cost-Effectiveness Analysis
    Jarmul, Jamie
    Pletcher, Mark J.
    Lich, Kristen Hassmiller
    Wheeler, Stephanie B.
    Weinberger, Morris
    Avery, Christy L.
    Jonas, Daniel E.
    Earnshaw, Stephanie
    Pignone, Michael
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2018, 11 (04):
  • [35] OVERVIEW OF RISK-ESTIMATION TOOLS FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASES IN EUROPEAN POPULATIONS
    Gorenoi, Vitali
    Hagen, Anja
    CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH, 2015, 23 (02) : 91 - 99
  • [36] Primary prevention of cardiovascular disease: global cardiovascular risk assessment and management in clinical practice
    Law, Tamryn K.
    Yan, Andrew T.
    Gupta, Aanika
    Kajil, Mahesh
    Tsigoulis, Michelle
    Singh, Narendra
    Verma, Subodh
    Gupta, Milan
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2015, 1 (01) : 31 - 36
  • [37] Risk scores for primary prevention of cardiovascular disease: Refinement and evaluation required
    Brindle, P
    Beswick, A
    HEART, 2005, 91 : A42 - A42
  • [38] Statins for primary prevention of cardiovascular disease and the risk of acute kidney injury
    Coste, Joel
    Karras, Alexandre
    Rudnichi, Annie
    Dray-Spira, Rosemary
    Pouchot, Jacques
    Giral, Philippe
    Zureik, Mahmoud
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 (12) : 1583 - 1590
  • [39] Primary prevention interventions to reduce cardiovascular disease risk: A review of reviews
    Whiting, D.
    Critchley, J.
    Unwin, N.
    Capewell, S.
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2008, 62 : A7 - A7
  • [40] Risk scoring in primary prevention of atherosclerotic cardiovascular disease: Strengths and limitations
    De Backer, Guy G.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (14) : 1531 - 1533